George Smith Alexander

India’s ONGC, HK-listed United Energy said to vie for $2b Chevron’s Bangladesh asset

Chevron is seeking buyers for Asian geothermal assets that could fetch as much as $3 billion and is also holding talks to sell assets in Indonesia and

India: Essar Group said to near sale of $6.5b refinery unit

Essar Group, controlled by India’s billionaire Ruia brothers, is nearing a final agreement to sell control of its refinery unit to Russian energy gi

India: IDBI Bank picks bankers to manage $896m share sale

The deal is expected to include an institutional share sale and a separate offering of preferential securities. The preferential shares could be sold

Malaysia’s telecom major Axiata seeks buyers for overseas holdings, move may fetch $700m

The Kuala Lumpur-based company is seeking a buyer for about 11% of Indonesian unit PT XL Axiata, which has a market value of $2.2b. It is also selling

Indian auto supplier Motherson Sumi plans to raise $300m from share sale

Indian automotive supplier Motherson Sumi Systems Ltd is poised to raise $300 million in a share sale after Yes Bank Ltd scrapped India’s biggest of

India: Ajay Piramal mulls IPOs for two units to boost market value of group

Piramal, 61, who sold his branded generic drugs unit to Abbott Laboratories for $3.8 billion in 2010, seeks to boost market value of the group by reva

India: Essar said to face asset sale challenge from IDFC private equity

India: Aditya Birla Group may sell 5% stake in finance unit ahead of listing

The group is seeking to raise at least $200 million through the stake sale. The conglomerate will consider selling around a 5 per cent stake in the un

India’s biggest bourse NSE said to seek arrangers to manage IPO

As many as 10 investors in the exchange, including Tiger Global Five Holdings, Norwest Ventures Partners X FII - Mauritius and State Bank of India, ha

Indian pharma player Claris said to start sale of $500m U.S. injectables unit

Shanghai Fosun Pharmaceutical Group Co. agreed last month to acquire 86 percent of Indian injectable-drug maker Gland Pharma Ltd. for as much as $1.26